McKesson Earnings Gain Gets Support From Oncology and GLP-1 Demand
Zacks points to growth across several businesses, while pricing pressure and weaker Medical-Surgical results remain risks for the distributor.

Every Stocks story we have published, newest first.
79 stories in the last 24 hours
Updated 5:55 AM (Times shown in New York time (ET))
Page 6 of 23 · 550 stories
Zacks points to growth across several businesses, while pricing pressure and weaker Medical-Surgical results remain risks for the distributor.

The publisher points to modest sales growth, a cautious revenue outlook and declining earnings in its case against the equipment maker.

Anthony Lee cited slow five-year sales growth, operating losses and declining earnings per share in his cautious view of Mercury Systems.

The mid-cap value strategy started a new position in Armstrong during the second quarter, citing improved valuation and strong fundamentals.

Cooke & Bieler named MKS its biggest contributor in the second quarter, citing AI-related demand and a stronger-than-expected quarterly report.

StockStory flagged weak per-share earnings growth and debt, while Hercules shares had gained 19.4% over the prior six months.

The investment firm added the engineering company in Q2, pointing to water-related work and opportunities for growth despite a near-term revenue headwind.

The investor letter cited strong hospitality results, Desert Ridge’s early performance and a possible sale of Ryman’s entertainment business.

StockStory points to a shrinking store base, negative operating margins and debt exceeding cash as reasons for caution on TLYS.

StockStory cited five-year sales growth, unchanged returns on invested capital and an expected flat cash-flow margin in its cautious view.

StockStory flagged five-year sales growth and cash-flow concerns, while calling YETI’s forward earnings valuation fair.

The publisher points to modest income forecasts and slower per-share earnings growth, while the shares have lagged the S&P 500 over six months.

A proposed cash acquisition gives Integer shareholders a defined price, while slow adoption of new products weighs on quarterly sales and margins.

The publisher cites Marvell’s growth and Yum’s margins, while pointing to declining sales and profitability at Moderna.

DocuSign’s customer growth, wider margins and stronger cash generation accompanied its sharp three-month stock rally.

The publisher highlighted Ameriprise, Mastercard and PJT Partners, citing revenue growth, share repurchases and other measures in its analysis.

The 25-year renewal keeps Cboe's exclusive S&P 500 options rights in place and leaves 2026 royalty fees unchanged.

The retailer has until October 19 to propose a compliance plan, while its Nasdaq listing remains unaffected for now.

Nasdaq closed its compliance matter after Liminatus shares stayed above $1 for 13 consecutive trading days following a 1-for-50 reverse split.

The company says the move is intended to help meet Nasdaq’s minimum bid-price rule; outstanding shares are set to fall to 650,686.

The research publisher highlights revenue and cash-flow trends at two companies, while pointing to slower profitability growth at PNC.

Specialty testing, acquisitions and margin gains support expansion, while higher costs and reimbursement changes remain risks.

Dr. Raluca Dinu will lead the ceremony, which the company says will recognize Breast Cancer Awareness Month and spotlight breast health.

Summit gained after AstraZeneca agreed to invest $2 billion, while CarMax beat earnings forecasts and FICO faced a new scoring framework.
